Related references
Note: Only part of the references are listed.ABLGenomic Editing Sufficiently Abolishes Oncogenesis of Human Chronic Myeloid Leukemia Cells In Vitro and In Vivo
Shu-Huey Chen et al.
CANCERS (2020)
HDAC1,2 Knock-Out and HDACi Induced Cell Apoptosis in Imatinib-Resistant K562 Cells
Shu-Huey Chen et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2019)
HDAC1 and HDAC2 Double Knockout Triggers Cell Apoptosis in Advanced Thyroid Cancer
Ching-Ling Lin et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2019)
CRISPR/Cas9 Genome Editing of Epidermal Growth Factor Receptor Sufficiently Abolished Oncogenicity in Anaplastic Thyroid Cancer
Li-Chi Huang et al.
DISEASE MARKERS (2018)
The Application of Non-Invasive Apoptosis Detection Sensor (NIADS) on Histone Deacetylation Inhibitor (HDACi)-Induced Breast Cancer Cell Death
Kai-Wen Hsu et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2018)
Clinical implications of the BRAF mutation in papillary thyroid carcinoma and chronic lymphocytic thyroiditis
Woon Won Kim et al.
JOURNAL OF OTOLARYNGOLOGY-HEAD & NECK SURGERY (2018)
Intensity-Modulated Radiation Therapy With or Without Concurrent Chemotherapy in Nonanaplastic Thyroid Cancer with Unresectable or Gross Residual Disease
Thomas H. Beckham et al.
THYROID (2018)
Use of multitarget tyrosine kinase inhibitors to attenuate platelet-derived growth factor signalling in lung disease
Rana Kanaan et al.
EUROPEAN RESPIRATORY REVIEW (2017)
Dynamic Patterns of Clonal Evolution in Tumor Vasculature Underlie Alterations in Lymphocyte-Endothelial Recognition to Foster Tumor Immune Escape
Daniel M. Corey et al.
CANCER RESEARCH (2016)
Tissue-based map of the human proteome
Mathias Uhlen et al.
SCIENCE (2015)
Overexpression of Platelet-derived Growth Factor-D as a Poor Prognosticator in Endometrial Cancer
Jie Ding et al.
ASIAN PACIFIC JOURNAL OF CANCER PREVENTION (2014)
Genome-Scale CRISPR-Cas9 Knockout Screening in Human Cells
Ophir Shalem et al.
SCIENCE (2014)
PK10453, a nonselective platelet-derived growth factor receptor inhibitor, prevents the progression of pulmonary arterial hypertension
Venkatrao Medarametla et al.
PULMONARY CIRCULATION (2014)
Platelet-derived growth factors and their receptors: Structural and functional perspectives
Po-Han Chen et al.
BIOCHIMICA ET BIOPHYSICA ACTA-PROTEINS AND PROTEOMICS (2013)
Expression and prognostic value of VEGFR-2, PDGFR-β, and c-Met in advanced hepatocellular carcinoma
Jie Sheng Chu et al.
JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH (2013)
Chemoresistance to gemcitabine in hepatoma cells induces epithelial-mesenchymal transition and involves activation of PDGF-D pathway
Qiong Wu et al.
ONCOTARGET (2013)
VEGF, PF4 and PDGF are elevated in platelets of colorectal cancer patients
Jon E. Peterson et al.
ANGIOGENESIS (2012)
PDGFRA promoter polymorphisms are associated with the risk of papillary thyroid cancer
Mi-Ja Kim et al.
MOLECULAR MEDICINE REPORTS (2012)
The Cancer Cell Line Encyclopedia enables predictive modelling of anticancer drug sensitivity
Jordi Barretina et al.
NATURE (2012)
A novel function for platelet-derived growth factor D: induction of osteoclastic differentiation for intraosseous tumor growth
W. Huang et al.
ONCOGENE (2012)
被撤回的出版物: Platelet-derived growth factor-D contributes to aggressiveness of breast cancer cells by up-regulating Notch and NF-κB signaling pathways (Retracted article. See vol. 158, pg. 605, 2016)
Aamir Ahmad et al.
BREAST CANCER RESEARCH AND TREATMENT (2011)
Resistance to BRAF Inhibitors: Unraveling Mechanisms and Future Treatment Options
Jessie Villanueva et al.
CANCER RESEARCH (2011)
A Novel Signaling Axis of Matriptase/PDGF-D/β-PDGFR in Human Prostate Cancer
Carolyn V. Ustach et al.
CANCER RESEARCH (2010)
Cytotoxic Chemotherapy for Differentiated Thyroid Carcinoma
S. I. Sherman
CLINICAL ONCOLOGY (2010)
BRAF Mutation in Papillary Thyroid Carcinoma: Pathogenic Role and Clinical Implications
Kam-Tsun Tang et al.
JOURNAL OF THE CHINESE MEDICAL ASSOCIATION (2010)
Overexpression and Activation of the α9-Nicotinic Receptor During Tumorigenesis in Human Breast Epithelial Cells
Chia-Hwa Lee et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2010)
Stromal PDGFRβ Expression in Prostate Tumors and Non-Malignant Prostate Tissue Predicts Prostate Cancer Survival
Christina Hagglof et al.
PLOS ONE (2010)
Increased Expression of Vascular Endothelial Growth Factor and Its Receptors, VEGFR-1 and VEGFR-2, in Medullary Thyroid Carcinoma
Clarissa Capp et al.
THYROID (2010)
V600E BRAF mutations are alternative early molecular events in a subset of KIT/PDGFRA wild-type gastrointestinal stromal tumours
A. Agaimy et al.
JOURNAL OF CLINICAL PATHOLOGY (2009)
PDGF BB induces VEGF secretion in ovarian cancer
Daniela Matei et al.
CANCER BIOLOGY & THERAPY (2007)
Suppression of BRAF/MEK/MAP kinase pathway restores expression of iodide-metabolizing genes in thyroid cells expressing the V600E BRAF mutant
Dingxie Liu et al.
CLINICAL CANCER RESEARCH (2007)
Cancer statistics, trends, and multiple primary cancer analyses from the surveillance, epidemiology, and end results (SEER) program
Matthew J. Hayat et al.
ONCOLOGIST (2007)
Autocrine PDGFR signaling promotes mammary cancer metastasis
Martin Jechlinger et al.
JOURNAL OF CLINICAL INVESTIGATION (2006)
Vascular endothelial growth factor in thyroid cancers
JD Lin et al.
CANCER BIOTHERAPY AND RADIOPHARMACEUTICALS (2005)
Differential role of platelet granular mediators in angiogenesis
A Brill et al.
CARDIOVASCULAR RESEARCH (2004)
Ligand-targeted therapeutics in anticancer therapy
TM Allen
NATURE REVIEWS CANCER (2002)
Human breast carcinoma desmoplasia is PDGF initiated
ZM Shao et al.
ONCOGENE (2000)
Share Paper
